Hydroxyzine Pamoate 51655-0252
Product NDC
51655-0252- Manufacturer
- Northwind Health Company, Llc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 25, 2023
- Listing Expires
- December 31, 2027
- Application
- ANDA088487
Need to source Hydroxyzine Pamoate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hydroxyzine Pamoate | 50 mg/1 |
Drug Class
Antihistamine [EPC]Histamine Receptor Antagonists [MoA]
Packaging Options(1)
30 CAPSULE in 1 BOTTLE, PLASTIC (51655-252-52)